Parallel trade, GSK and the ECJ: the beauty of equivocation
This article was originally published in SRA
Executive Summary
The European Court of Justice (ECJ) Judgement in the recent GlaxoSmithKline versus Greek wholesalers case smacks of little more than fence-sitting, suggests Edward Miller, Partner at international law firm Reed Smith. “I think the legal arguments that the Court has come up with are slightly different than the ones that have been kicked around before, but I think that the practical consequence of it is that it is going to change very little,” Mr Miller told EURALex.